{"id":396733,"date":"2025-04-19T01:05:00","date_gmt":"2025-04-18T23:05:00","guid":{"rendered":"https:\/\/medizinonline.com\/no-habra-mas-trasplantes-para-el-lh-recidivante-o-refractario-en-el-futuro\/"},"modified":"2025-04-19T00:21:03","modified_gmt":"2025-04-18T22:21:03","slug":"no-habra-mas-trasplantes-para-el-lh-recidivante-o-refractario-en-el-futuro","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/es\/no-habra-mas-trasplantes-para-el-lh-recidivante-o-refractario-en-el-futuro\/","title":{"rendered":"\u00bfNo habr\u00e1 m\u00e1s trasplantes para el LH recidivante o refractario en el futuro?"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>El enfoque terap\u00e9utico est\u00e1ndar para el linfoma de Hodgkin (LH) cl\u00e1sico recidivante o refractario (RR) tras el fracaso del tratamiento de primera l\u00ednea es la terapia de segunda l\u00ednea con el objetivo de alcanzar la remisi\u00f3n completa (RC), seguida de una consolidaci\u00f3n con terapia de dosis altas y trasplante aut\u00f3logo de c\u00e9lulas hematopoy\u00e9ticas (HDT\/AHCT). Los investigadores estudiaron si en el futuro podr\u00eda prescindirse del trasplante en determinadas condiciones. <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Fno-habra-mas-trasplantes-para-el-lh-recidivante-o-refractario-en-el-futuro%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>El enfoque terap\u00e9utico est\u00e1ndar para el linfoma de Hodgkin (LH) cl\u00e1sico recidivante o refractario (RR) tras el fracaso del tratamiento de primera l\u00ednea es la terapia de segunda l\u00ednea con&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Fno-habra-mas-trasplantes-para-el-lh-recidivante-o-refractario-en-el-futuro%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":396735,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Linfoma de Hodgkin  ","footnotes":""},"category":[11552,11483,11475,11321,11336],"tags":[81780,25759,12942,81814,15829,30272],"powerkit_post_featured":[],"class_list":["post-396733","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-es","category-el-congreso-informa","category-estudios","category-hematologia","category-oncologia","tag-ash-2024-es","tag-hl-es","tag-linfoma-de-hodgkin-es","tag-linfoma-de-hodgkin-es-3","tag-pembrolizumab-es","tag-trasplante","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-13 11:55:13","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"es_ES","wpml_translations":[],"_links":{"self":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/396733","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/comments?post=396733"}],"version-history":[{"count":2,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/396733\/revisions"}],"predecessor-version":[{"id":398461,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/396733\/revisions\/398461"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media\/396735"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media?parent=396733"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/category?post=396733"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/tags?post=396733"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/powerkit_post_featured?post=396733"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}